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Abstract
Background: Alcohol abuse results in problems on various levels in society. In terms of health, alcohol abuse is not 
only an important risk factor for chronic disease, but it is also related to injuries. Social harms which can be related to 
drinking include interpersonal problems, work problems, violent and other crimes. The scope of societal costs related 
to alcohol abuse in principle should be the same for both economic evaluations and cost-of-illness studies. In general, 
economic evaluations report a small part of all societal costs. To determine the cost- effectiveness of an intervention it 
is necessary that all costs and benefits are included. The purpose of this study is to describe and quantify the difference 
in societal costs incorporated in economic evaluations and cost-of-illness studies on alcohol abuse.
Method: To investigate the economic costs attributable to alcohol in cost-of-illness studies we used the results of a 
recent systematic review (June 2009). We performed a PubMed search to identify economic evaluations on alcohol 
interventions. Only economic evaluations in which two or more interventions were compared from a societal 
perspective were included. The proportion of health care costs and the proportion of societal costs were estimated in 
both type of studies.
Results: The proportion of healthcare costs in cost-of-illness studies was 17% and the proportion of societal costs 83%. 
In economic evaluations, the proportion of healthcare costs was 57%, and the proportion of societal costs was 43%.
Conclusions: The costs included in economic evaluations performed from a societal perspective do not correspond 
with those included in cost-of-illness studies. Economic evaluations on alcohol abuse underreport true societal cost of 
alcohol abuse. When considering implementation of alcohol abuse interventions, policy makers should take into 
account that economic evaluations from the societal perspective might underestimate the total effects and costs of 
interventions.
Introduction
Alcohol abuse results in problems on various levels in
society. In terms of health, alcohol abuse is not only an
important risk factor for chronic disease, but it is also
related to unintentional and intentional injuries [1-3]. On
the social level the WHO Expert Committee on Problems
Related to Alcohol Consumption reported that social
harms which can be related to drinking include interper-
sonal problems, work problems, violent and other crimes
[2].
From the economic point of view, the estimated tangi-
ble costs of alcohol in the European Union were €125 bil-
lion in 2003, including €59 billion worth of lost
productivity through absenteeism, unemployment and
lost working years due to premature death [4]. Another
study reported that the weighted average costs in four
high-income countries (France, USA, Scotland and Can-
ada) were 1.4% of the gross domestic product [3].
To reduce the negative effect of alcohol abuse it is nec-
essary for countries to develop an alcohol policy and
implement prevention programs. An alcohol policy can
be defined as a set of measures in a jurisdiction or society
aimed at minimizing the health and social problems from
alcohol consumption [2]. The alcohol abuse prevention
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programs as developed, focus on one of more of the strat-
egies of the WHO: reducing the availability of alcohol,
alcohol prices and taxes, restricting the sale of alcohol,
restrictions on alcohol marketing, drink-driving counter-
measures, education and persuasion [2,5].
Before an intervention may be implemented, a firm evi-
dence base for its effectiveness is needed. The effects of
an intervention should be both statistically significant
and clinically relevant.
In light of increasing health care costs and limited
resources, interventions aimed at reducing alcohol abuse
should not only be effective, but efficient or cost-effective
too. Nowadays, policy makers require information about
the effectiveness of an intervention in relation to its costs.
The perspective of an economic evaluation of an alcohol
abuse intervention should be taken into account in the
decision making process. If a study is performed from a
health care perspective only costs are included which are
related to health care use. A study performed from a
social perspective includes both healthcare costs and all
relevant societal costs. In the case of an alcohol abuse
intervention performed from the societal perspective,
costs due to productivity losses, crime and law enforce-
ment costs also have to be included, in addition to health
care costs. Taking into account the public interest, it is
important for a policy maker that all costs related to
excessive alcohol use are included in an economic evalua-
tion. In other words: to be able to make a clear decision
whether getting good value for the money when intro-
ducing a preventive intervention, a policymaker needs
economic evaluations that include all related societal
costs.
Cost-of illness studies which are performed according
to the international guidelines of the WHO report all type
of healthcare cost and societal costs comprehensively [6].
From economic evaluations from the societal perspec-
tive, it is not known whether all types of societal costs are
taken into account. To determine the cost- effectiveness
of an intervention it is necessary that all costs and bene-
fits are included. The purpose of this study is to describe
the cost components and to quantify the difference in
societal costs incorporated in economic evaluations and
cost-of-illness studies on alcohol abuse. For the compari-
son of costs incorporated in economic evaluations and in
cost-of-illness studies, we do not focus on marginal cost
differences between interventions, but rather concentrate
on included pre-intervention costs in economic evalua-
tions only.
Method
A recently published review summarizes the costs attrib-
utable to alcohol abuse as involved in cost-of illness stud-
ies [3]. One of the purposes of that review was to analyze
the full societal effect of alcohol, since cost-of-illness
studies are not restricted to health but usually include
criminal outcomes and other social detriments. We
selected four of the 29 identified cost-of-illness studies.
Those studies were methodologically most comparable
i.e. those estimating the gross costs and using the same
discount rate. Those were studies of high income coun-
tries (France, US, Scotland and Canada). We calculated
the per-study (unweighted) average proportion of health
care costs and societal costs of those four cost-of-illness
studies [3]. The types of costs involved in those studies
are: total healthcare costs, prevention and research costs,
public order and safety costs, criminal damage costs,
drink-driving costs, work-related costs, the loss of reve-
nues from compulsory taxes, property damage and pre-
mature mortality in the non working population. For the
per-study average proportion of healthcare costs, we
counted total health care costs and prevention and
research costs. T o have an estimate of the total societal
costs, we counted all other type of costs.
To identify economic evaluations on alcohol interven-
tions, we performed a PubMed search. The search con-
tained the terms: alcohol abuse, alcohol misuse,
economic evaluation, cost-effectiveness, cost-utility, life
year gained, QALY, prevention, preventive intervention
and societal perspective. We searched for economic eval-
uations that were reported between 2000 and 2009 in
English. We only included full economic evaluations per-
formed from the societal perspective in which two or
more interventions on alcohol abuse were compared with
each other or with usual care [7]. Of the included studies
the per-study (unweighted) average proportion of health-
care cost and societal costs at baseline were calculated for
the intervention groups. The proportion of the health
care costs and the proportion of the societal costs were
compared in both cost-of-illness studies and economic
evaluations.
To be able to compare the outcomes of cost-of-illness
studies and economic evaluations with different base
years and different currency units, all local currencies
were first transferred to the euro currency values of that
time, following the advice of the Organization for Eco-
nomic Co-operation and Development, and then recalcu-
lated to 2008, the year that was chosen as base year for
the current study [8,9].
Results
Cost-of-illness studies
Table 1 shows the results of the cost-of-illness studies.
Differences in types of societal costs that were included in
the four investigated cost-of-illness studies were
observed. All studies included public order and safety
costs and work-related (productivity) costs, and all but
one study did include drink-driving costs [10,12]. Produc-
tivity costs were estimated using the 'human capital'v
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Table 1: The costs as reported in four included cost-of-illness studies (recalculated into million 2008€) and the proportion Health Care costs and Societal costs (%)
Study Healthcare 
costs
Prevention 
and 
research 
costs
Total 
Health Care 
costs
Proportion 
Health care 
costs (%)
Public 
order and 
safety costs
Criminal 
damage 
costs
Drink-driving 
costs
Work-related 
costs
Cost of the 
losses in 
compulsory 
taxes
Total 
Societal 
costs
Proportion 
societal 
costs
Total 
costs
Fenoglio 
(France)
3,500 698 4,198 19 70 4,393 10,936 2,333. 17,732 81 21,930
Harwood 
(USA)
28,074 1,860 29,934 15 779 8,966 17,948 141,497 164,811 85 198,345
Varney 
(Scotland)
155 3 158 9 142 442 1025 1,608 91 1,766
Rehm 
(Canada)
2,678 110 2,788 24 2,488 127 613 5,772 9,001 76 11,789v
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Table 2: The types of baseline costs as reported in five economic evaluations (2008€) and the proportion Health Care costs and Societal costs (%)
Study Healthcare 
costs
Prevention 
and research 
costs
Total 
Heath 
Care costs
Proportion 
Health Care 
costs (%)
Public 
order and 
safety costs
Criminal 
damage 
costs
Drink-
driving 
costs
Work-
related 
costs
Cost of the 
losses in 
compulsory 
taxes
Total 
societal 
cost
Proportion 
Societal 
costs (%)
Total 
costs
Barrett 4,523 4,523 53 3,146 665 153 3,964 47 8,487
Parrott1 Intervention 1 1,087 74 1,161 35 69 2,099 2,168 65 3,329
Intervention 2 2,367 627 2,994 60 274 1,759 2,033 40 5,027
Rychlik 1,666 10 1,676 77 488 488 23 2,164
Solberg 2,418 2,418 33 5,007 5,007 67 7,425
UKATT1 Intervention 1 2,678 2,678 74 83 856 939 26 3,617
Intervention 2 2,991 2,991 70 144 1130 1,274 30 4,265van Gils et al. Cost Effectiveness and Resource Allocation 2010, 8:15
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approach. Other societal types of costs were only
reported in one cost-of-illness study [13].
Averaged over all the cost-of-illness studies, the pro-
portion of the healthcare costs was 17% of the total cost
due to alcohol abuse. The societal costs attributed to 83%
of the total alcohol abuse costs.
Economic evaluations
Our literature search on economic evaluations of preven-
tive interventions directed at alcohol abuse conducted in
July 2009, identified 116 potentially relevant studies.
After having read the abstracts, we selected 34 articles to
read in full, of those we included 5 studies because these
studies satisfied our inclusion criterion [14,18]. Reasons
for excluding 29 studies were that those were not per-
formed from a societal perspective or were not full eco-
nomic evaluations. One of included studies was a
modeling study [17], the other four were original
research. Two of the studies used the QALY as an out-
come measure [17,18], while the other studies presented
the outcome in surrogate endpoints: reduction in alcohol
consumption [14,15] or number of successfully treated
persons [16].
Table 2 shows the types of costs involved in the eco-
nomic evaluations and the absolute cost figures. Health-
c a r e  c o s t s  w e r e  r e p o r t e d  i n  a l l  i n c l u d e d  e c o n o m i c
evaluations, and prevention and research costs were
included in four of five economic evaluations [14,17].
Focusing on societal costs, there were large differences in
types of costs that were included. Four studies included
public order and safety costs [14,15,17,18], and two stud-
ies included work related costs, using the 'human capitol'
approach. There were no studies that included drink-
driving costs and costs of losses in compulsory taxes. We
only report the cost components and the absolute costs
before the start of an intervention and do not pay atten-
tion to incremental or marginal costs.
Averaged over all economic evaluations the proportion
of the healthcare costs at baseline was 57% of the total
cost, and of the societal costs amounted for 43%.
Discussion
Our study shows that the scope of societal costs included
in five economic evaluations with a societal perspective
was smaller than the scope of societal costs as incorpo-
rated in four cost-of-illness studies. We found only 5 full-
economic evaluation studies on preventive interventions
of alcohol abuse. None of the economic evaluations
included all types of societal costs that were represented
in the cost-of-illness studies. This means that, although it
is claimed that the societal perspective is taken, the soci-
etal costs as reported in economic evaluations are incom-
p l e t e  i n  g e n e r a l .  I n  r e l a t i o n  t o  a l c o h o l  a b u s e  i t  i s
remarkable that none of the studies included drink-driv-
ing costs. Only two studies included work-related costs
due to productivity losses. These results corresponds
with the findings of Barbosa et al. that a societal perspec-
tive has never been taken into full account in economic
evaluations [19]. The four cost-of-illness studies used to
identify the healthcare and societal costs of alcohol abuse
present those costs clearly in general. The only exception
is that Fenoglio et al. did not include criminal damage
[13].
Averaged over all economic evaluations, the proportion
of healthcare costs (57%) and societal cost (43%) does not
correspond with the proportion as reported in cost-of-ill-
ness studies (17% and 83%, respectively). So, the incre-
mental cost-effectiveness ratios (ICER) that are reported
in economic evaluations might be underestimations of
the true societal costs and effects of preventive interven-
tions directed at alcohol abuse.
It is known that economic evaluations of alcohol abuse
interventions performed from a healthcare perspective
underestimate true costs, because only healthcare costs
are involved in this kind of studies. It will be useful to pol-
icy makers if studies make clear how a life-style interven-
tion directed towards alcohol abuse affects both the
health care costs and the societal costs [20]. Studies that
claim to be done from a societal perspective show an
underestimation too. The real part of societal costs will
be much higher than presented in those economic evalu-
ations.
Comparing productivity costs between studies is ham-
pered by the existence of two 'schools' that address the
issue of valuation of productivity losses in an entirely dif-
ferent manner. Advocates of the friction cost approach
come-up with relatively modest estimates of productivity
losses, whereas those using the human capital approach
may easily reach estimates that are ten to hundred times
higher than those generated by frictionists. There is no
easy solution to this problem, and both approaches may
hold best arguments, depending on the local circum-
stances of the analysis. In the meantime, absolute clarity
about methodology used to derive productivity costs esti-
mates is indispensable.
Two studies presented the QALY as an outcome. In
studies done from a healthcare perspective the QALY as
an outcome measure is almost standard practice.
Although economic evaluations presenting the QALY as
outcome measure are more or less comparable with each
other, the way the QALY is measured in a public-health
intervention performed from a societal perspective is
debatable. The questionnaires to estimate the QALY are
directed on health status, while in a societal perspective
also other benefits besides healthcare, like social welfare,
should be involved; these are not included in those ques-
tionnaires [21]. In general, it will be useful to think about
the method used to make an economic evaluation of pub-van Gils et al. Cost Effectiveness and Resource Allocation 2010, 8:15
http://www.resource-allocation.com/content/8/1/15
Page 6 of 7
lic health programs. Recent literature gives arguments to
change from the cost effectiveness/cost-utility analyses to
cost-benefit analyses (CBA). CBA does assess how social
welfare is affected by an intervention, by identifying and
measuring all costs and benefits. All gains, also health
gains, are expressed in monetary terms [22]. Clearly this
would represent a more holistic approach to evaluation of
different alcohol policy measures. However, for obvious
reasons, CBA is rare in all economic evaluations, not only
for those of public health programmes.
Some limitations of this study have to be taken into
account. We calculated per-study averaged total health-
care costs and societal costs, but it is quite difficult to
compare costs as reported in different economic evalua-
tions. This was due to differences in study design, out-
come measures, discount rates, et cetera. For example,
three studies used 'preventing the decrease of drinking'
and 'abstinence' as a surrogate outcome measure.
Another limitation is that the cost-of-illness studies
showed also differences in the types of costs involved in
the studies. That means that a full comparison of the
studies is not really possible, although these studies are
more complete than the economic evaluations. Further-
more, in the original studies, it is not always clear which
costs are placed under the types of costs. It will be possi-
ble that 'property damage' costs for instance are placed
under the topic 'criminal damage'.
Conclusion
The costs included in economic evaluations on alcohol
abuse interventions performed from a societal perspec-
tive do not correspond with those included in cost-of-ill-
ness studies on alcohol abuse. It is obvious that alcohol
abuse not only affects health care costs, but has also a big
influence on societal costs. Productivity losses account
for the largest proportion of the total costs. Therefore, it
is important that all economic evaluations report produc-
tivity costs in the same way, to ensure comparability
among studies.
Policy makers need to have data based on real life, i.e.
all societal costs (next to all health care costs) should be
included in economic evaluations from the societal per-
spective. It can be concluded from the results of this
study, that this is not the case in most economic evalua-
tions. In considering whether good value for the money is
achieved when introducing a preventive intervention,
policy makers should take into account that the result
from an economic evolution from the societal perspec-
tive might be an underestimation of the true costs and
effects of the intervention.
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